MUSC Launches New Vasculitis Clinic, Innovating Patient Care and Research

The Medical University of South Carolina (MUSC) is proud to announce the establishment of a new Vasculitis Clinic, led by rheumatologist Kathleen Maksimowicz-McKinnon, D.O., MPH, associate professor in the MUSC Division of Rheumatology & Immunology. This specialized clinic will provide personalized, comprehensive care to patients with vasculitis, granting them access to cutting-edge treatments while fostering advancements in research within the field.

Dr. McKinnon's passion for rheumatology and her commitment to improving patient outcomes have driven the development of this cutting-edge clinic. With a focus on interdisciplinary collaboration, clinical trials, and addressing unmet needs, the Vasculitis Clinic represents a major milestone in the treatment of this complex disease.

Vasculitis is a multisystem condition that poses significant challenges to both patients and healthcare providers. The MUSC Vasculitis Clinic will provide a multidisciplinary approach to care, working closely with specialists from various medical subspecialties, including pulmonology, nephrology, ENT, infectious diseases, ophthalmology, dermatology, cardiology, and neurology. This collaborative effort ensures comprehensive and personalized care for every patient.

"I am thrilled to lead the Vasculitis Clinic at MUSC and contribute to the advancements in treating this challenging disease," said Dr. McKinnon. "Our interdisciplinary approach allows us to address the complex nature of vasculitis and develop individualized treatment plans based on each patient's unique needs."

The Vasculitis Clinic will also play a crucial role in advancing research in the field. Dr. McKinnon's research interests include developing safer and more effective treatments, reducing infections in vasculitis patients, and improving monitoring protocols. The clinic will actively participate in clinical trials and collaborate with biotechnology companies to explore innovative infection identification and prevention approaches. Additionally, they will study the immune system's response to treatments and infections to work on predictive models to identify patients at higher risk for complications.

"I believe that collaborative work and research are key to advancing treatment and care for patients with vasculitis," added Dr. McKinnon. "Through our partnerships and clinical trials, we aim to provide better outcomes and improve the quality of life for our patients."

The MUSC Vasculitis Clinic has experienced a significant increase in patient volume since its inception, not only from South Carolina but also from surrounding states. Dr. McKinnon has implemented a triage process to ensure immediate care for these often seriously ill patients, collaborating closely with local rheumatologists to coordinate care and maintain continuity. This collaborative approach ensures that patients receive the best possible outcomes and support.

To learn more about services available, schedule an appointment, or schedule a referral, please call 843-876-0615.

For more information about the MUSC Health Vasculitis Center, please visit the MUSC Health Vasculitis website.